Stifel Financial’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,081
Closed -$41.8K 3408
2024
Q1
$41.8K Sell
15,081
-10,707
-42% -$29.7K ﹤0.01% 3268
2023
Q4
$43.8K Sell
25,788
-7,425
-22% -$12.6K ﹤0.01% 3232
2023
Q3
$34.2K Buy
33,213
+150
+0.5% +$155 ﹤0.01% 3210
2023
Q2
$38.4K Sell
33,063
-1,596
-5% -$1.85K ﹤0.01% 3253
2023
Q1
$52.3K Sell
34,659
-1,222
-3% -$1.85K ﹤0.01% 3231
2022
Q4
$89.7K Sell
35,881
-11,298
-24% -$28.2K ﹤0.01% 3147
2022
Q3
$199K Sell
47,179
-428
-0.9% -$1.81K ﹤0.01% 2958
2022
Q2
$133K Sell
47,607
-1,720
-3% -$4.81K ﹤0.01% 3109
2022
Q1
$282K Sell
49,327
-2,711
-5% -$15.5K ﹤0.01% 2907
2021
Q4
$475K Sell
52,038
-11,822
-19% -$108K ﹤0.01% 2616
2021
Q3
$683K Sell
63,860
-25,506
-29% -$273K ﹤0.01% 2380
2021
Q2
$1.39M Buy
89,366
+2,241
+3% +$34.8K ﹤0.01% 1857
2021
Q1
$1.41M Buy
87,125
+13,166
+18% +$213K ﹤0.01% 1751
2020
Q4
$1.57M Sell
73,959
-5,909
-7% -$125K ﹤0.01% 1539
2020
Q3
$1.18M Buy
79,868
+407
+0.5% +$6.03K ﹤0.01% 1519
2020
Q2
$1.17M Sell
79,461
-65,274
-45% -$960K ﹤0.01% 1450
2020
Q1
$1.69M Buy
144,735
+14,745
+11% +$172K ﹤0.01% 1130
2019
Q4
$3.05M Buy
129,990
+20,670
+19% +$484K 0.01% 1095
2019
Q3
$2.04M Buy
109,320
+859
+0.8% +$16K 0.01% 1302
2019
Q2
$2.03M Buy
108,461
+51,658
+91% +$965K 0.01% 1324
2019
Q1
$1.37M Buy
+56,803
New +$1.37M ﹤0.01% 1470
2018
Q3
Sell
-28,134
Closed -$1.09M 2785
2018
Q2
$1.09M Buy
+28,134
New +$1.09M ﹤0.01% 1554